SATURDAY
08:00 – 10:00 | SEMINAR I – NEONATAL BLOOD CELLS
Chair: O. Andres; H. Morbach, Würzburg, Germany
Recent concepts in treating neonatal thrombocytopenia
R. D. Christensen, Salt Lake City, USA
Erythrocyte transfusions: Benefits and limits
H. Kirpalani, Philadelphia, USA
Interactive Discussion
10:00 | COFFEE BREAK
10:30 – 12:30 | SEMINAR II – OPTIMAL TREATMENT STRATEGIES FOR RDS
Chair: C. O’Donnell, Dublin, Ireland; C. C. Roehr, Bristol/Oxford, UK
Latest European guidelines on the treatment of RDS
D. Sweet, Belfast, Northern Ireland
Do we have an optimal ventilation strategy for the treatment of very preterm infants?
R. Sindelar, Uppsala, Sweden
Interactive Discussion
12:30 | LUNCH BREAK
13:30 – 15:30 | SEMINAR III – FUTURE CONCEPTS FOR THE PREVENTION OF NEONATAL MORBIDITY
Chair: A. te Pas, Leiden, The Netherlands; L. van Wyk, Capetown, South Africa
Tele-Neonatology and AI for preventing short-term neonatal morbidity
E. Giannoni, Lausanne, Switzerland
The adult preterm phenotype: Inescapable destiny or preventable outcome?
D. Singer, Hamburg, Germany
Interactive Discussion
15:30 | COFFEE BREAK
16:00 – 18:00 | SEMINAR IV – NUTRITION
Chair: M. Hei, Beijing, China; J. M. Solano, Bogota, Columbia
Drawing reliable inferences from large observational data sets to guide neonatal care when randomised trials are not possible
N. Modi, London, UK
Nutritional requirements and feeding strategies for the neonate
A. Liubsys, Vilnius, Lithuania
Interactive Discussion
PRIMAL II WORKSHOP
“Priming immune-microbiome interaction early in life and consequences for long term health”
09:00 – 10:30 | I. NEONATAL INFECTION
Chair: K. Glaser, Tübingen, Germany; E. Herting, Lübeck, Germany
How to leverage network data on neonatal infection from Eastern Europe
J. Seliga-Sewicka, Warsaw, Poland
Genetic risk for neonatal infection and associated outcomes
W. Göpel, Lübeck, Germany
Development of guideline on infection management in preterm infants
V. Dimopoulou; E. Giannoni, Lausanne, Switzerland
Round table
10:30 | COFFEE BREAK
11:00 – 12:30 | II. INFLAMMATION AT INTERFACES
Chair: U. Felderhoff-Müser, Essen, Germany; C. Klingenberg, Tromsö, Norway
Immune-gut-brain interaction and hypoxic-ischemic encephalopathy
J. Herz, Essen, Germany
Immune system and organ axes in preterm infants
C. Pietrasanta, Milano, Italy
Early life antibiotics and impact on organ development
L. Aunsholt, Copenhagen, Denmark
The psychosocial context matters
J. Jäkel, Düsseldorf, Germany
Round table
13:00 | LUNCH BREAK
14:00 – 15:30 | III. NUTRITION AND IMMUNE-MICROBIOME INTERACTION
Chair: R. Knoll, San Francisco, USA; D. Podlesny, Heidelberg, Germany
Enteral feeding of preterm infants
S. Ojha, Nottingham, UK
Update on the conundrum of NEC
J. Neu, Gainesville, USA
Between gut feeling and evidence: The role of probiotics
R. Soll, Burlington, USA
Clinical relevance of early life microbiome diagnostics
D. Bogaert, Edinburgh, UK
Round table
15:30 | COFFEE BREAK
16:00 – 17:30 | IV. PREVENTION NOW AND TOMORROW
Chair: W.S. Park, Seoul, South Korea; M. Stocker, Luzerne Switzerland
How to protect preterm skin?
T. Strunk, Perth, Australia
Impact of RSV immunization in neonates on infection burden
G. Engels, Würzburg, Germany
Stem cell therapy to prevent inflammation
B. Thebaud, Ottawa, Canada
Priming at the beginning of life and long-term health
D. Viemann, Würzburg, Germany
Round table
18:00 – 20:00 | SCIENTIFIC FLASH TALKS
Neonatal infection- case scenario (simulation lab)
J. Marißen, K. Ruf, P. Paul, Würzburg, Germany
VASCULAR ACCESS WORKSHOP
Ultrasound, Decision-Making & Device Security
16:00 | THE MANY USES OF ULTRASOUND
Fiammetta Piersigilli
Beyond insertion: ultrasound across the vascular access pathway
16:20 | FROM REACTIVE TO PROACTIVE
Roland van Rens
Moving from inertia to planning.
16:40 | US FOR CENTRALLY INSERTED CENTRAL CATHETERS
Robin van der Lee
From vessel assessment to successful catheter placement
Videos
17:20 | US FOR UVC AND n-PICCs
Fiammetta Piersigilli
Improving tip location and reducing uncertainty
17:40 | SECURE AND PROTECT
Roland van Rens
Stabilisation, protection and prevention of catheter failure
18:00 | PRACTICAL STATIONS
POCUS Station
Micro Seldinger Technique Station
Fixation and Stabilisation Station
SUNDAY
08:15 | OPENING
C. Härtel and C.P. Speer, Würzburg, Germany
I. THE GOLDEN HOUR OF LIFE
Chair: H. Kirpalani, Philadelphia, USA; O. D. Saugstad, Oslo, Norway
08:30 | How to facilitate cardiopulmonary transition?
M. Vento Torres, Valencia, Spain
09:30 | Optimal techniques and devices for neonatal resuscitation
C.C. Roehr, Bristol/Oxford, UK
10:00 | PANEL DISCUSSION
10:30 | COFFEE BREAK
11:00 | PAOLO CHIESI PRIZE FOR EXCELLENCE IN NEONATOLOGY
II. LESS INVASIVE RESPIRATORY CARE IN 2027
Chair: D. Sweet, Belfast, Northern Ireland; E. Herting, Lübeck, Germany
11:15 | Less invasive surfactant strategies: State-of-the-art
C. Härtel, Würzburg, Germany
11:45 | Can video laryngoscopy help to intubate and to administer surfactant successfully?
C. O’ Donnell, Dublin, Ireland
12:15 | An endless story: Finding the optimal PEEP?
H. Kirpalani, Philadelphia, USA
12:45 | PANEL DISCUSSION
13:15 | LUNCH BREAK
III. APNEA AND SEPSIS: EXPERIENCE VS. EVIDENCE
Chair: C. Klingenberg, Tromsø, Norway; S. Anderson, Helsinki, Finnland
14:15 | How to create best possible evidence?
R. Soll, Burlington, USA
14:45 | Strategies for prevention and treatment of apnea
B. Schmidt, Philadelphia, USA
15:15 | Neonatal Sepsis: Where are we in 2027?
T. Strunk, Perth, Australia
15:45 | PANEL DISCUSSION
16:15 | COFFEE BREAK
IV. BPD AND LIFELONG BURDEN
Chair: K. Glaser, Tübingen, Germany; M. Hallman, Oulu, Finland
16:45 | BPD: Still an unresolved problem
S. Kotecha, Cardiff, UK
17:15 | The lifelong burden of BPD
K. Rabe, Großhansdorf, Germany
17:45 | Can machine learning and artificial intelligence help to improve neonatal care
E. Giannoni, Lausanne, Switzerland
18:15 | PANEL DISCUSSION
18:45 | Adjourn
MONDAY
V. BRAIN INJURY AND NEUROPROTECTION
Chair: U. Felderhoff-Müser, Essen Germany; M. Hei, Beijing, China
08:15 | Neuroprotection in HIE: New Concepts in Trial Design and Therapies
N. J. Robertson, Edinburgh, UK
08:45 | Brain injury of preterm infants: The Damocles sword continues to swing
D. Edwards, London, UK
09:15 | Neonatal seizures
R. Pressler, London, UK
09:45| PANEL DISCUSSION
10:15 | COFFEE BREAK
VI. SEVERE NEONATAL MORBIDITIES
Chair: S. Mukhopadhyay, Philadelphia, USA; M. Vento Torres, Valencia, Spain
11:00 | How to reduce neonatal morbidity and mortality in LMIC?
J. Haddad, Beirut, Lebanon
11:30 | NEC: The mystery goes on
J. Neu, Gainesville, USA
12:00 | ROP- treatment: Do we have the answer yet?
A. Hellström, Gothenburg, Sweden
12:30 | PANEL DISCUSSION
13:00 | LUNCH BREAK
VII. PREVENTIVE STRATEGIES
Chair: L. Aunsholt, Copenhagen, Denmark; N. Modi, London, UK
14:00 | Implementing best practice in preterm enteral care in 2027
S. Ojha, Nottingham, UK
14:30 | The danger of Kernikterus
R. D. Christensen, Salt Lake City, USA
15:00 | Antibiotic stewardship in neonatology
M. Stocker, Zürich, Switzerland
15:30 | PANEL DISCUSSION
16:00 | ADJOURN
